These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33418990)

  • 1. The
    Meshkov A; Ershova A; Kiseleva A; Zotova E; Sotnikova E; Petukhova A; Zharikova A; Malyshev P; Rozhkova T; Blokhina A; Limonova A; Ramensky V; Divashuk M; Khasanova Z; Bukaeva A; Kurilova O; Skirko O; Pokrovskaya M; Mikova V; Snigir E; Akinshina A; Mitrofanov S; Kashtanova D; Makarov V; Kukharchuk V; Boytsov S; Yudin S; Drapkina O
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33418990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center study.
    Setia N; Movva S; Balakrishnan P; Biji IK; Sawhney JPS; Puri R; Arora A; Puri RD; Saxena R; Mishra S; Apte S; Kulshrestha S; Ramprasad VL; Verma IC
    J Clin Lipidol; 2020; 14(1):35-45. PubMed ID: 32044282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic spectrum of familial hypercholesterolemia in the central south region of China.
    Xiang R; Fan LL; Lin MJ; Li JJ; Shi XY; Jin JY; Liu YX; Chen YQ; Xia K; Zhao SP
    Atherosclerosis; 2017 Mar; 258():84-88. PubMed ID: 28235710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
    Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
    Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
    Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
    Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
    Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
    Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
    Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
    Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
    Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India.
    Reddy LL; Shah SAV; Ponde CK; Dalal JJ; Jatale RG; Dalal RJ; Rajani RM; Pillai SK; Vanjani CV; Ashavaid TF
    J Hum Genet; 2021 Oct; 66(10):983-993. PubMed ID: 33864011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia.
    Lv X; Wang C; Liu L; Yin G; Zhang W; Abdu FA; Shi T; Zhang Q; Che W
    Lipids Health Dis; 2023 Oct; 22(1):175. PubMed ID: 37853441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the Mutational Spectrum of Hungarian Patients with Familial Hypercholesterolemia.
    Madar L; Juhász L; Szűcs Z; Kerkovits L; Harangi M; Balogh I
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation.
    Sun D; Zhou BY; Li S; Sun NL; Hua Q; Wu SL; Cao YS; Guo YL; Wu NQ; Zhu CG; Gao Y; Cui CJ; Liu G; Li JJ
    Lipids Health Dis; 2018 Nov; 17(1):252. PubMed ID: 30400955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.
    Khera AV; Won HH; Peloso GM; Lawson KS; Bartz TM; Deng X; van Leeuwen EM; Natarajan P; Emdin CA; Bick AG; Morrison AC; Brody JA; Gupta N; Nomura A; Kessler T; Duga S; Bis JC; van Duijn CM; Cupples LA; Psaty B; Rader DJ; Danesh J; Schunkert H; McPherson R; Farrall M; Watkins H; Lander E; Wilson JG; Correa A; Boerwinkle E; Merlini PA; Ardissino D; Saleheen D; Gabriel S; Kathiresan S
    J Am Coll Cardiol; 2016 Jun; 67(22):2578-89. PubMed ID: 27050191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.
    Mabuchi H; Nohara A; Noguchi T; Kobayashi J; Kawashiri MA; Inoue T; Mori M; Tada H; Nakanishi C; Yagi K; Yamagishi M; Ueda K; Takegoshi T; Miyamoto S; Inazu A; Koizumi J;
    Atherosclerosis; 2014 Sep; 236(1):54-61. PubMed ID: 25014035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
    Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.
    Chora JR; Medeiros AM; Alves AC; Bourbon M
    Genet Med; 2018 Jun; 20(6):591-598. PubMed ID: 29261184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.
    Wang H; Yang H; Liu Z; Cui K; Zhang Y; Zhang Y; Zhao K; Yin K; Li W; Zhou Z
    J Atheroscler Thromb; 2020 Dec; 27(12):1288-1298. PubMed ID: 32759540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing.
    Razman AZ; Chua YA; Mohd Kasim NA; Al-Khateeb A; Sheikh Abdul Kadir SH; Jusoh SA; Nawawi H;
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries.
    Alhababi D; Zayed H
    Atherosclerosis; 2018 Dec; 279():62-72. PubMed ID: 30415195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.